37 news items
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
CKPT
5 Jun 24
. Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPT
CKPT
3 Jun 24
is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel treatments
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
CKPT
31 May 24
to participate in the action. Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CKPT
CKPT
30 May 24
]
Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CKPT
CKPT
28 May 24
the class action] Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses
ywctlar77qsles6z71m7wwiejef295hy1m4pmelum2qogt
CKPT
22 May 24
]
Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development
dqgc175 zd03s0xo8
CKPT
21 May 24
and targeted oncology company that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor
9altzk1 hvka55n2qz8busz7kk8e96c1e7jslxlw5aatd6j4fa31m
CKPT
20 May 24
the class action] Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses
ernesl lg1ct3iyznm3gmjk1hplrza1va
CKPT
HRT
OCGN
16 May 24
, 2024 Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition
f32dl0nf33wpgnw365yeoftn06mn4m2s14g5t2umyofukilexxfiqmw9cw
CKPT
16 May 24
immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor
1dm otbod
CKPT
16 May 24
HC Wainwright & Co. analyst Joseph Pantginis reiterates Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and maintains $34 price target.
rtg3n ad9ge9h6sd57v4ypnagth37g7o2v
CKPT
DERM
FBIO
15 May 24
of cosibelimab. We intend to seek to address the feedback in a potential BLA resubmission, which is currently targeted for mid-year. Cosibelimab
dzdcvj0we048s0v290h7hfwl8774btntoiocei309h jg
CKPT
FBIO
13 May 24
") (NASDAQ:CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer
f643jpfrpg27e3kq0n5e9itgh1
CKPT
HRT
OCGN
12 May 24
is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel
wvrjz94g2fqt7 uat9nwqu1fbvi7txsb
CKPT
12 May 24
joining the class action] Checkpoint is a clinical-stage immunotherapy and targeted oncology company
i9hv11ny wdml623n
CKPT
FBIO
10 May 24
") (NASDAQ:CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first quarter ended March 31, 2024
op0g5qm0xl0ya 51gjmyqxcj
CKPT
HRT
OCGN
7 May 24
Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel
k2zjomxng1rcggv3jivomxt4imsiea4q klsryr17q8yuc0
CKPT
6 May 24
]
Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development
uihoppzpj0wtpan40gssf5wpu3b
ADSK
CKPT
PERI
2 May 24
Lead Plaintiff Deadline: June 4, 2024 Checkpoint is a clinical-stage immunotherapy and targeted oncology company
wlhzzp7 kiwld
CKPT
2 May 24
the class action] Checkpoint is a clinical-stage immunotherapy and targeted oncology company that focuses